Today: 21 March 2026
Browse Category

NASDAQ:HRMY 13 January 2026

Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

Harmony Biosciences shares fell 6.4% to $35.82 Tuesday after the company cut its Fragile X program and issued 2026 sales guidance. Harmony forecast Wakix net revenue of $1.0–$1.04 billion for 2026 and confirmed it will phase out ZYN002. Preliminary Wakix revenue for 2025 was about $868 million. CEO Jeffrey Dayno is set to present at the J.P. Morgan Healthcare Conference later Tuesday.
13 January 2026

Stock Market Today

  • Tesco Shares Face Major Risk From War-Driven Food Inflation Ahead of April Results
    March 21, 2026, 4:01 AM EDT. Tesco shares have remained steady but face significant risk from rising food price inflation, driven by costs linked to the war in Iran and disruptions in key commodity supplies such as fertiliser and urea, which have surged 50%. Investors watch how Tesco will manage input cost increases and whether it can pass these on to consumers without losing sales. The grocery sector's tight profit margins mean that failure to do so could squeeze profits. Tesco trades at a price-to-earnings ratio of 21 with a dividend yield of 3%, but war-driven inflation poses a looming threat ahead of its April 16 annual results. Past supply chain resilience offers cautious optimism.
Go toTop